Represents an inventory impairment charge of $1.3 million related to the January 2026 voluntary recall of select lots of bioidentical hormone pellets shipped by Asteria Health between May 2025 and ...

IRVING, Texas--(BUSINESS WIRE)-- Biote (BTMD) (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, ...

Earnings call Biote reported Q4 2025 revenue of $46.4M, down 6.9% YoY, with procedure revenue declining 13% and dietary supplement revenue up 16%. Gross margin fell to 68% due to a recall-related ...

IRVING, Texas--(BUSINESS WIRE)-- biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”) a leading solutions provider in preventive health care through the delivery of personalized hormone optimization ...

We recently published a list of 10 Micro-Cap Stocks Insiders Were Buying In Q1 2025. In this article, we are going to take a look at where biote Corp. (NASDAQ:BTMD) stands against other micro-cap ...

(MENAFN- EIN Presswire) EINPresswire/ -- OBGYN Specialists of Columbus is helping women better understand Bioidentical Hormone Replacement Therapy, including what BioTE pellet therapy involves, how ...

IRVING, Texas--(BUSINESS WIRE)-- biote Corp., (Nasdaq: BTMD) (“Biote” or the “Company”), a high growth, differentiated medical practice-building business within the hormone optimization space, today ...

Image source: The Motley Fool. biote (NASDAQ:BTMD) reported lower total and procedure revenues, attributed to elevated clinic attrition and a voluntary product recall, but offset these pressures with ...

IRVING, Texas--(BUSINESS WIRE)-- Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today ...

IRVING, Texas, March 11, 2026--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our practitioners’ patients ...